Combination therapy of peptide vaccination and estramustine treatment
US7718614B2 · kind B2 · utility
4Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2006 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Jul 5, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/884
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a prostate cancer, which comprises administering a therapeutically effective amount of a cancer antigen peptide-associated agent and a lower dose of an estramustine or a salt thereof to a patient in need thereof, and a pharmaceutical composition thereof are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.